Atea Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -14.03M-10.95M121.19M-115.91M-135.96M-168.38M
Share-based Compensation 0.41M0.62M7.46M39.62M46.72M49.43M51.77M
Gains from Sales and Divestitures 0.02M
Gains from Investment Securities 10.52M2.94M
Non-cash Items 3.25M31.24M
Cash from Operations -7.91M-12.83M296.73M-87.00M-120.98M-85.39M-135.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 5.46M15.45M11.82M
Depreciation & Amortization (CF) 0.02M0.02M0.02M0.03M0.26M0.42M0.42M
Change in Working Capital
Change in Receivables 5.82M
Change in Account Payables -0.09M0.16M-0.49M10.29M-1.98M1.70M0.21M
Change in Accured Expenses 0.73M0.45M12.44M43.88M-37.62M12.66M-13.42M
Investing Activities
Capital Expenditures 0.01M0.00M0.03M0.00M1.94M
Change in Acquisitions & Divestments 91.89M602.66M517.28M
Cash from Investing Activities -0.01M-0.00M-0.03M-0.00M-455.41M40.30M56.10M
Financing Activities
Change in Capital Stock
Shares Issued 0.12M317.61M1.47M0.23M0.26M0.27M
Shares Repurchased 0.66M
Preferred Shares Issued 27.36M214.12M
Misc.
Cash from Financing Activities 27.48M531.75M1.47M0.37M0.26M0.27M
Change in Cash 19.56M-12.83M828.46M-85.54M-576.02M-44.84M-79.13M
Free Cash Flow -7.92M-12.83M296.71M-87.01M-122.92M-85.39M-135.50M
Net Cash Flow 19.56M-12.83M828.46M-85.54M-576.02M-44.84M-79.13M